Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dolby Laboratories (DLB) Shares Outstanding (2016 - 2025)

Dolby Laboratories (DLB) has disclosed Shares Outstanding for 17 consecutive years, with $34.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding fell 41.96% year-over-year to $34.7 million, compared with a TTM value of $34.7 million through Sep 2025, down 41.96%, and an annual FY2025 reading of $34.7 million, up 36772.34% over the prior year.
  • Shares Outstanding was $60.8 million for Q3 2025 at Dolby Laboratories, up from $95000.0 in the prior quarter.
  • Across five years, Shares Outstanding topped out at $65.0 million in Q3 2021 and bottomed at $94000.0 in Q2 2023.
  • Average Shares Outstanding over 5 years is $14.4 million, with a median of $98500.0 recorded in 2022.
  • The sharpest move saw Shares Outstanding plummeted 43.76% in 2021, then soared 65.71% in 2022.
  • Year by year, Shares Outstanding stood at $100000.0 in 2021, then decreased by 5.0% to $95000.0 in 2022, then dropped by 1.05% to $94000.0 in 2023, then grew by 1.06% to $95000.0 in 2024, then soared by 36384.21% to $34.7 million in 2025.
  • Business Quant data shows Shares Outstanding for DLB at $34.7 million in Q3 2025, $95000.0 in Q1 2025, and $95000.0 in Q4 2024.